11-47342698-G-C

Variant names:

• chr11-47342698-G-C
• rs375882485
• NM_000256.3:c.1504C>G

Variant summary

Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM1 PM2 PM5 PP3_Moderate PP5

The NM_000256.3(MYBPC3):​c.1504C>G​(p.Arg502Gly) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R502Q) has been classified as Pathogenic.

• Frequency: Genomes: not found (cov: 33)
• Consequence: MYBPC3 NM_000256.3 missense
• Clinical Significance: Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1 U:1
• Conservation: PhyloP100: 4.49

Genes affected

MYBPC3 (HGNC:7551): (myosin binding protein C3) MYBPC3 encodes the cardiac isoform of myosin-binding protein C. Myosin-binding protein C is a myosin-associated protein found in the cross-bridge-bearing zone (C region) of A bands in striated muscle. MYBPC3 is expressed exclusively in heart muscle and is a key regulator of cardiac contraction. Mutations in this gene are a frequent cause of familial hypertrophic cardiomyopathy. [provided by RefSeq, May 2022]

ACMG classification

Verdict is Likely_pathogenic. Variant got 9 ACMG points.

• PM1: In a domain Ig-like C2-type 3 (size 90) in uniprot entity MYPC3_HUMAN there are 33 pathogenic changes around while only 9 benign (79%) in NM_000256.3
• PM2: Very rare variant in population databases, with high coverage
• PM5: Other missense variant is known to change same aminoacid residue: Variant chr11-47342697-C-T is described in Lovd as [Pathogenic].
• PP3: MetaRNN computational evidence supports a deleterious effect, 0.918
• PP5: Variant 11-47342698-G-C is Pathogenic according to our data. Variant chr11-47342698-G-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 1475570.We mark this variant Likely_pathogenic, oryginal submissions are: {Uncertain_significance=1, Likely_pathogenic=1}.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
MYBPC3	NM_000256.3	c.1504C>G	p.Arg502Gly	missense_variant	Exon 17 of 35	ENST00000545968.6	NP_000247.2

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
MYBPC3	ENST00000545968.6	c.1504C>G	p.Arg502Gly	missense_variant	Exon 17 of 35	5	NM_000256.3	ENSP00000442795.1
MYBPC3	ENST00000399249.6	c.1504C>G	p.Arg502Gly	missense_variant	Exon 16 of 34	5		ENSP00000382193.2
MYBPC3	ENST00000544791.1	n.1504C>G		non_coding_transcript_exon_variant	Exon 17 of 27	5		ENSP00000444259.1

Frequencies

GnomAD3 genomes Cov.: 33

GnomAD4 exome Cov.: 31

GnomAD4 genome Cov.: 33

ClinVar

Significance: Conflicting classifications of pathogenicity

Submissions summary: Pathogenic:1 Uncertain:1

Revision: criteria provided, conflicting classifications

Submissions by phenotype

Cardiovascular phenotype Pathogenic:1

Dec 01, 2022

Ambry Genetics

Significance: Likely pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

The p.R502G variant (also known as c.1504C>G), located in coding exon 17 of the MYBPC3 gene, results from a C to G substitution at nucleotide position 1504. The arginine at codon 502 is replaced by glycine, an amino acid with dissimilar properties. This alteration has been reported in individuals with hypertrophic cardiomyopathy (HCM) (Liu X et al. Sci Rep, 2015 Jun;5:11411; Harper AR et al. Nat Genet, 2021 Feb;53:135-142; Ambry internal data). Two other alterations at the same codon, p.R502Q (c.1505G>A) and p.R502W (c.1504C>T), have been detected in multiple unrelated patients with HCM, including individuals with pediatric and adult-onset HCM, and has been reported to segregate with disease in families (Nimura etal. N Engl J Med. 1998;338:1248-1257; Richard P et al. Circulation. 2003;107(17):2227-32; Cardmin N etal. Rev Port Cardiol. 2005;24:1463-147; Van Driest SL et al. J Am Coll Cardiol. 2004;44(9):1903-10; Rudzinski T etal. Kardiol Pol. 2008;66:821-825; Saltzman AJ et al. Circ Res. 2010;106(9):1549-52; Kaski JP et al. Circ Cardiovasc Genet. 2012;5(3):317-26; Otsuka H et al. Circ. J. 2012;76(2):453-61; Maurizi N et al. JAMA Cardiol. 2018;3(6):520-525). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. -

Hypertrophic cardiomyopathy Uncertain:1

Jan 30, 2025

Labcorp Genetics (formerly Invitae), Labcorp

Significance: Uncertain significance

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 502 of the MYBPC3 protein (p.Arg502Gly). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with hypertrophic cardiomyopathy (PMID: 24704860, 26090888). ClinVar contains an entry for this variant (Variation ID: 1475570). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. This variant disrupts the p.Arg502 amino acid residue in MYBPC3. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 9562578, 16566405, 18403758, 18533079, 20433692, 22386539). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
AlphaMissense	Pathogenic	0.58
CardioboostCm	Uncertain	0.89
BayesDel_addAF	Pathogenic	0.37	D
BayesDel_noAF	Pathogenic	0.29
CADD	Pathogenic	26
DANN	Uncertain	1.0
DEOGEN2	Uncertain	0.75	D;T;T
Eigen	Pathogenic	0.76
Eigen_PC	Pathogenic	0.68
FATHMM_MKL	Uncertain	0.97	D
LIST_S2	Uncertain	0.95	D;D;D
M_CAP	Pathogenic	0.51	D
MetaRNN	Pathogenic	0.92	D;D;D
MetaSVM	Uncertain	0.20	D
MutationAssessor	Uncertain	2.9	M;.;.
PrimateAI	Uncertain	0.65	T
PROVEAN	Pathogenic	-5.8	D;.;D
REVEL	Pathogenic	0.71
Sift	Uncertain	0.0020	D;.;D
Sift4G	Pathogenic	0.0010	D;D;D
Vest4		0.90
MVP		0.90
MPC		0.94
ClinPred		0.99	D
GERP RS		4.6
Varity_R		0.61
gMVP		0.82

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs375882485; hg19: chr11-47364249;